Brussels, April 18, 2018 – Oliver Götz is a serial entrepreneur in the healthcare sector, with a specific technology expertise. He is the founder and CEO of LabVenture, a holding company investing in the healthcare and IT sector and also the founder and Executive Chairman of ThinxNet, a fast-growing start-up founded in 2014 providing IoT (Internet of Things) based services for the automotive industry.
In 1998, Mr. Götz founded with financial investors (Bridgepoint and Atlas Venture) LabNet AG, the first private lab-chain in Germany where he remained COO until 2001. In 2001, he then founded Lab’Partners, a company managing more than 100 hospital-labs in Germany, which he merged in 2008 within the amedes Group, an international provider of interdisciplinary and medical-diagnostic services. Mr. Götz remained a shareholder and Member of the Executive Board of amedes until its sale to Antin Infrastructure Fund in 2015.
He earned a master in Medical Computer Science and graduated with honors at the Technical University of Munich.
Ergon’s Board of Senior Advisors consists of a senior group of seasoned business executives from the geographies and sectors targeted by Ergon. It meets on a regular basis to review Ergon’s investment strategy and provide insight to Ergon’s management team.
Wolfgang de Limburg, Managing Partner of Ergon stated: “We are delighted to welcome Oliver, a true entrepreneur, as Senior Advisor to Ergon. His broad healthcare and technology expertise will bring further depth to Ergon’s healthcare sector focus and support the value creation process at our portfolio companies.”
About Ergon Capital Partners
Ergon is a mid-market private equity investment company with ~€1.0 billion under management backed by family-controlled Groupe Bruxelles Lambert, through its fully owned subsidiary Sienna Capital, as cornerstone investor, and selected European institutional investors. Ergon is a disciplined and discreet value investor, which provides “patient and friendly capital” to entrepreneurs and managers, who need capital and industrial solutions to accelerate the development of their companies. Ergon makes equity investments from €25 million up to €75 million in leading companies with a sustainable competitive position in attractive niche markets located in the Benelux, France, Germany, Italy, Iberia and Switzerland. Ergon is advised by Ergon Capital Advisors which has offices in Brussels, Paris, Munich, Milan and Madrid. Since its inception in 2005, over successive investment programs, Ergon raised approximately €1.4 billion, invested in 18 companies (of which 5 in the Benelux, 2 in France, 3 in Germany, 7 in Italy and 1 in Spain) and has completed 33 add-on acquisitions for a total aggregate transaction value in excess of €3.0 billion. Ergon’s current portfolio consists of 8 companies in various sectors encompassing luxury, specialty retail, industrial manufacturing and services, healthcare, media, leisure and gastronomy.
For more information on Ergon Capital Partners visit www.ergoncapital.com